Delivery Order SPE2DB22D2206-SPE2DB25FJH29
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ramelteon 8 mg tablets. The contract, valued at $2,098.57, is a firm fixed-price delivery order with an ultimate completion date of September 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of ramelteon 8 mg tablets, a prescription sleep medication, to the Defense Logistics Agency (DLA). The $1,178.16 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance ending on February 13, 2025 and was not subject to any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $248,280 delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg tablets of ramelteon. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a leading distributor of drugs to the U.S. military, Amerisourcebergen will fulfill this order from the Defense Logistics Agency to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $966 to Amerisourcebergen Drug Corporation. The order is for 4561557398 Ramelteon 8 mg tablets to be delivered within a one-day period ending July 21, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, any set aside designations, or involvement of major subcontractors. The...
- This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $29,160 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 8 mg Ramelteon tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 21-24, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies and pharmaceuticals are...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $213.24 to Amerisourcebergen Drug Corporation. The order is for 4561664839 Ramelteon 8 mg tablets to be delivered in quantities of 30 tablets per package. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with work to be completed between August 1st and 2nd of 2023. The Defense Logistics Agency functions to support the resupply needs of the United States Department of...